HTBX News and Press, Heat Biologics Inc. From 01/06/21

Zolovax, Inc., a wholly-owned subsidiary of Heat Biologics (HTBX), has entered into an exclusive license agreement with the University of Miami for its UMIP-510 platform. Heat Biologics has also promoted William Ostrander as Chief Financial Officer with effect from January 4, 2021.The ag...

Palm Beach, FL – December 17, 2020 – Glioblastoma multiforme (GBM) is the most common and aggressive malignant brain tumor in humans that involves glial cells. GBM is present in two variants namely, giant cell glioblastoma and gliosarcoma. Gliomas are tumors arising from glial...

Sio Gene Therapies (SIOX) +42% on positive AXO-AAV-GM1 data in nerve cell disorder.Good Times Restaurants (GTIM) +27% on Q4 results.Tilray (TLRY) +27% as company to combine with Aphria to create largest global cannabis company.DAVIDsTEA (DTEA) +25% on Q3 results.NeuBa...

Heat Biologics (HTBX) rises 14% premarket after completing its gp96-based COVID-19 vaccine cell line ("ZVX-60"), being developed for use as either a standalone, or in combination with other vaccines to enhance prophylactic protection.Data, generated at the University of Mi...

Preparations for manufacturing underway DURHAM, NC / ACCESSWIRE / December 16, 2020 / Heat Biologics, Inc. ("Heat") (NASDAQ:HTBX) , a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, including multiple oncology pro...

Heat Biologics (NASDAQ:HTBX) is down -14.1% as the company announces a reverse stock split of 1-for-7 effective tomorrow.The corporate action intended address the reduce concerns related to the Nasdaq minimum bid price requirement will reduce the number of i...

DURHAM, NC / ACCESSWIRE / December 10, 2020 / Heat Biologics, Inc. ("Heat") (NASDAQ:HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, including multiple oncology product candidates and a novel COVID-19 vaccine, tod...

FinancialBuzz.com News Commentary New York, NY (11/16/2020) – New restrictions are being implemented in several states across the country as the number of those infected with COVID-19 is once again on the rise. For instance, New York City’s new restrictions went in...

Can These 4 Biotech Penny Stocks Bring in the Bulls? Biotech penny stocks have been on a big bull run since March of this year. With Covid on the rise around the world, investors are continuing to pay more attention to biotech stocks. Now, not all biotech stocks deal with Covid-rela...

Pfizer and BioNTech's announcement that, based on preliminary data, their COVID-19 vaccine is 90% effective and an emergency use authorization ((EUA)) is only weeks away has led to downward pressure on some of the second tier developers. If all goes according to plan, deployment could start b...